| GTO ID | GTD0340 |
| Accession | E-MTAB-11315 |
| Gene therapy-related clinical trial | GTC2404 |
| Altered gene | S |
| Gene xrefs |
Gene ID:
1489668
|
| Treatment | ARCT-021(ARCT COVID-19 vaccine) |
| Control | Click to openARCT.101.5104.Day29_06;ARCT.101.5108.Day29_02;ARCT.101.5109.Day29_04;ARCT.101.5116.Day29_05;ARCT.101.6103.Day29_11;ARCT.101.6108.Day29_02;ARCT.101.6110.Day29_08;ARCT.101.6111.Day29_11;ARCT.101.7103.Day29_05;ARCT.101.7105.Day29_09;ARCT.101.7108.Day29_03;ARCT.101.7115.Day29_05;ARCT.101.8105.Day29_03;ARCT.101.8106.Day29_06;ARCT.101.8109.Day29_03;ARCT.101.8112.Day29_12 |
| Case | Click to openARCT.101.6101.Day29_05;ARCT.101.6102.Day29_08;ARCT.101.6104.Day29_02;ARCT.101.6105.Day29_05;ARCT.101.6106.Day29_08;ARCT.101.6107.Day29_11;ARCT.101.6109.Day29_05;ARCT.101.6112.Day29_02;ARCT.101.6113.Day29_05;ARCT.101.6114.Day29_08;ARCT.101.6115.Day29_11;ARCT.101.6116.Day29_02;ARCT.101.8101.Day29_03;ARCT.101.8102.Day29_06;ARCT.101.8103.Day29_09;ARCT.101.8104.Day29_12;ARCT.101.8107.Day29_09;ARCT.101.8108.Day29_12;ARCT.101.8110.Day29_06;ARCT.101.8111.Day29_09;ARCT.101.8113.Day29_03;ARCT.101.8114.Day29_06;ARCT.101.8115.Day29_01;ARCT.101.8116.Day29_04 |
| Disease | COVID-19 |
| Disease information |
Disease group: Infection Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2. Xref: DO:0080600 |
| Organism | Homo sapiens |
| Tissue/Cell type | blood |
| Characteristics | Day29;3 microgram |
| Strategy | Microarray |
| Platform | A-MTAB-668 |
| Gene Name | AveExpr Control | AveExpr Case | Log2FC | P-value | Adjusted P-value | Regulation | Boxplot |
|---|
| ID | Terms | Size | ES | NES | P-value | Adjusted P-value | Plot |
|---|